Fresenius SE & Co. KGaA (FSNUY)
- Previous Close
7.79 - Open
7.60 - Bid --
- Ask --
- Day's Range
7.52 - 7.73 - 52 Week Range
6.33 - 8.38 - Volume
68,102 - Avg. Volume
50,745 - Market Cap (intraday)
17.167B - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
44.82 - EPS (TTM)
0.17 - Earnings Date Jul 31, 2024
- Forward Dividend & Yield 0.25 (3.21%)
- Ex-Dividend Date May 18, 2023
- 1y Target Est
--
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
www.fresenius.com190,863
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FSNUY
Performance Overview: FSNUY
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FSNUY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FSNUY
Valuation Measures
Market Cap
17.10B
Enterprise Value
31.82B
Trailing P/E
44.43
Forward P/E
9.49
PEG Ratio (5yr expected)
0.27
Price/Sales (ttm)
0.71
Price/Book (mrq)
0.83
Enterprise Value/Revenue
1.31
Enterprise Value/EBITDA
10.74
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.95%
Return on Assets (ttm)
1.26%
Return on Equity (ttm)
0.75%
Revenue (ttm)
22.46B
Net Income Avi to Common (ttm)
312M
Diluted EPS (ttm)
0.17
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02B
Total Debt/Equity (mrq)
72.10%
Levered Free Cash Flow (ttm)
2.97B
Research Analysis: FSNUY
Company Insights: FSNUY
FSNUY does not have Company Insights